lottaove.blog.shinobi.jp Reviews
is lottaove.blog.shinobi.jp legit or scam?The trust score of lottaove.blog.shinobi.jp is very high. Why?
The provided content appears to be a blog post or a collection of blog posts. The content is in Japanese and seems to be related to personal activities, such as diary entries, artwork, and announcements about publications. It mentions various topics, including the release of a book, participation in an anthology, and the author’s experiences and thoughts. The content is not related to any scam or unsafe activities. It seems to be a personal blog or website for sharing the author’s creative work and updates on their projects.”
the reasons behind this review :
Personal blog or website for sharing creative work and project updates.
Positive Points | Negative Points |
---|---|
website content is accessible High review rate by AI Archive Age is quit old | Whois data is hidden |
How much trust do people have in lottaove.blog.shinobi.jp?
Domain age :
unknow
WHOIS data :
Hidden
Title :
HAPPINESS
Description :
活動とか日記とかラクガキとかね。
Website Rank :
N/A
Archive Age :
15 year(s) 9 month(s) 3 day(s)
SSL certificate valid :
Valid
SSL type :
Low - Domain Validated Certificates (DV SSL)
SSL issuer :
Let's Encrypt
IP : 202.228.215.58
ISP : AS4694 IDC Frontier Inc.
Country : JP
This website was last scanned on November 14, 2024
socialboss.org
The website socialboss.org offers services to buy followers, likes, and views for various social media platforms, including YouTube, Instagram, Facebook, Twitter, SoundCloud, Spotify, and others. The site claims to provide...
datarockets.com
Datarockets is a software development company that specializes in building web and mobile applications for startups and enterprises. The company's website provides information about their services, technologies, approach, and case...
santhera.com
https://santhera.com redirected to https//www.santhera.com during the time we crawled it. Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular...